Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

All New Biotech Specs
CNBC
Monday, October 11, 2010 - 8:23pm
tags:
biotech, Genzyme, Sanofi, Biomarin, Alexion
Approval of Questcor's Athcar Drawing Near
Seeking Alpha
Monday, October 11, 2010 - 6:01pm
tags:
Questcor Pharmaceuticals, Athcar, FDA, infantile spasms
With Meridia Gone, Can’t We Just Admit There’s No Money in Diet Drugs?
BNET Pharma
Monday, October 11, 2010 - 5:55pm
tags:
Meridia, diet drugs, Abbott Laboratories, GSK, Roche, Allergan, Novo Nordisk, Sanofi, Merck, Eli Lilly, Amylin, Takeda, Orexigen
Sanofi / Genzyme Battle Likely to End Somewhere in the Middle
Seeking Alpha
Monday, October 11, 2010 - 4:29pm
tags:
M&A, Genzyme, Sanofi
Geron shares rise on stem cell study
Yahoo/AP
Monday, October 11, 2010 - 11:30am
tags:
Geron, stem cells
Abbott Reports Psoriasis Phase III Results of Its Investigation
Bloomberg
Monday, October 11, 2010 - 11:23am
tags:
Abbott Laboratories, psoriasis
ImmunoGen climbs on cancer drug deal
Marketwatch
Monday, October 11, 2010 - 11:22am
tags:
Immunogen, Novartis, cancer
Novartis Halts Development of Two Drugs: Biotech's Latest Tribulations
Seeking Alpha
Monday, October 11, 2010 - 11:20am
tags:
Novartis, Actelion, AstraZeneca, Human Genome, JNJ, ONYX Pharmaceuticals, Pfizer, Rosetta Genomics, Targacept, Mycograb, albinterferon alfa-2b
J&J Drug for Prostate Cancer Extends Life in Company-Sponsored Research
Bloomberg
Monday, October 11, 2010 - 11:17am
tags:
JNJ, prostate cancer, abiraterone
FDA declines approval of Jazz drug for fibromyalgia
Reuters
Monday, October 11, 2010 - 11:16am
tags:
FDA, Jazz Pharmaceuticals, fibromyalgia
Lilly drops Alimta in head/neck cancer, test fails
Reuters
Monday, October 11, 2010 - 11:15am
tags:
head and neck cancer, Eli Lilly, Alimta
Will The Meridia Withdrawal Help Or Hurt Diet Pills?
Pharmalot
Monday, October 11, 2010 - 11:08am
tags:
Abbott Laboratories, Meridia, obesity, diet drugs
Warner Chilcott Announces FDA Approval of Next Generation Actonel
Yahoo
Monday, October 11, 2010 - 11:01am
tags:
Actonel, Warner Chilcott, osteoporosis
Risks vs. Benefits in Holding Alexza Through Approval of AZ-004
Seeking Alpha
Monday, October 11, 2010 - 10:59am
tags:
Alexza, AZ-004, Biovail
Exelixis, Bristol-Myers in $565M deal
Bizjournals.com
Monday, October 11, 2010 - 10:50am
tags:
Exelixis, Bristol-Myers Squibb
Merck KGaA’s Erbitux Delays Progression of Breast Cancer in Test
Bloomberg
Monday, October 11, 2010 - 10:48am
tags:
Merck KGaA, Erbitux, Eli Lilly, breast cancer
Pharma Job Cuts Just Keep On Coming
Seeking Alpha
Monday, October 11, 2010 - 10:27am
tags:
layoffs, Abbott Laboratories, Bristol-Myers Squibb, Endo, JNJ, Lonza, Lundbeck
AstraZeneca gets positive EU agreement on Vimovo
Marketwatch
Monday, October 11, 2010 - 10:26am
tags:
vivmo, Europe, AstraZeneca
Bristol-Myers Squibb continues tradition
FT.com
Monday, October 11, 2010 - 10:23am
tags:
Bristol-Myers Squibb, Lamberto Andreotti, Pharma CEOs
Uptrend Spotted in Shares of Par Pharmaceutical (PRX)
Benzinga
Sunday, October 10, 2010 - 12:23pm
tags:
Par Pharmaceutical, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.